Stockscreener 앱 받기
2.86
4.76%
0.13
시간 외 거래:
2.78
-0.08
-2.80%
Xortx Therapeutics Inc 주식(XRTX)의 최신 뉴스
XORTX shareholders approve up-to-5-for-1 share consolidation to meet Nasdaq rules - MSN
XORTX Therapeutics (NASDAQ: XRTX) registers up to 2.2M shares; $4.7M estimated proceeds - Stock Titan
XORTX Therapeutics | POS AM: Post-effective amendment to a registration statement that is not immediately effective upon filingmoomoo - Moomoo
XORTX Regains Nasdaq Listing Compliance After Reverse Stock Split - The Globe and Mail
XORTX Therapeutics (NASDAQ: XRTX) files F-1: 2.2M shares, pre-funded warrants - Stock Titan
XRTX SEC FilingsXortx Therapeutics Inc 10-K, 10-Q, 8-K Forms - Stock Titan
XRTX Stock Jumps As VB4-P5 Kidney Deal Expands Pipeline - StocksToTrade
XRTX Stock Jumps As Kidney Pipeline Expands With VB4-P5 Deal - StocksToTrade
XORTX Therapeutics jumps as it confirms Nasdaq bid-price compliance after reverse split - Quiver Quantitative
XORTX (NASDAQ: XRTX) cures Nasdaq minimum bid deficiency - Stock Titan
XRTX Jumps As New Kidney Fibrosis Deal Expands Pipeline - timothysykes.com
XORTX Therapeutics Says Met Nasdaq Continued Listing Requirements - marketscreener.com
XORTX Meets Nasdaq Continued Listing Requirements - GlobeNewswire
Promising Penny Stocks To Add to Your WatchlistApril 21st - MarketBeat
After 1-for-5 reverse split, XORTX clears Nasdaq $1 bid rule - Stock Titan
XORTX Therapeutics (XRTX) Stock: Insider Signals (Smart Money Outflows) 2026-04-20Real Trader Network - Cổng thông tin điện tử tỉnh Tây Ninh
XORTX (NASDAQ: XRTX) closes $3M VB4-P5 kidney anti-fibrotic deal - Stock Titan
Discontinued operations of XORTX Therapeutics, Inc. – DUS:ANU - TradingView — Track All Markets
Long term debt to total equity ratio of XORTX Therapeutics, Inc. – DUS:ANU - TradingView
EBITDA per share of XORTX Therapeutics, Inc. – DUS:ANU - TradingView
Xortx announces closing of acquisition of Vectus kidney anti-fibrotic asset - marketscreener.com
XORTX Announces Closing of Acquisition of Vectus Kidney Anti-fibrotic Asset - The Manila Times
Hedge Fund Moves: What is the target price for XORTX Therapeutics Inc stockProduct Launch & Free Expert Verified Stock Movement Alerts - baoquankhu1.vn
Is XORTX Therapeutics Inc vulnerable to short sellers2026 Price Action Summary & Real-Time Volume Analysis - baoquankhu1.vn
XORTX Therapeutics : Investor Presentation - marketscreener.com
Aug Update: Can XORTX Therapeutics Inc continue delivering strong returnsWeekly Trade Report & Free Expert Verified Stock Movement Alerts - baoquankhu1.vn
Bond Watch: Is XORTX Therapeutics Inc a speculative investmentWall Street Watch & Low Risk Entry Point Tips - baoquankhu1.vn
Long term debt to total equity ratio of XORTX Therapeutics, Inc. – TRADEGATE:ANU - TradingView — Track All Markets
XORTX Therapeutics Inc. R (ANUA.MU) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada
XORTX Therapeutics, Inc. Revenue Breakdown – LS:A427MJ - TradingView
Gross margin % of XORTX Therapeutics, Inc. – LS:A427MJ - TradingView — Track All Markets
Tangible book value per share of XORTX Therapeutics, Inc. – LSX:A427MJ - TradingView
XORTX Therapeutics, Inc. Balance Sheet – LS:A427MJ - TradingView — Track All Markets
Operating cash flow per share of XORTX Therapeutics, Inc. – LS:A427MJ - TradingView — Track All Markets
XORTX Therapeutics, Inc. Dividends – LS:A427MJ - TradingView — Track All Markets
Discontinued operations of XORTX Therapeutics, Inc. – LS:A427MJ - TradingView — Track All Markets
Operating margin % of XORTX Therapeutics, Inc. – LS:A427MJ - TradingView — Track All Markets
Discontinued operations of XORTX Therapeutics, Inc. – LSX:A427MJ - TradingView — Track All Markets
EBITDA margin % of XORTX Therapeutics, Inc. – LSX:A427MJ - TradingView — Track All Markets
Gross profit of XORTX Therapeutics, Inc. – LSX:A427MJ - TradingView — Track All Markets
Cash from investing activities of XORTX Therapeutics, Inc. – LS:A427MJ - TradingView — Track All Markets
Long term debt to total equity ratio of XORTX Therapeutics, Inc. – LSX:A427MJ - TradingView — Track All Markets
Preferred dividends of XORTX Therapeutics, Inc. – LSX:A427MJ - TradingView — Track All Markets
XORTX Therapeutics, Inc. Cash Flow – LSX:A427MJ - TradingView — Track All Markets
XORTX Therapeutics, Inc. Cash Flow – LS:A427MJ - TradingView — Track All Markets
Net income before discontinued operations of XORTX Therapeutics, Inc. – LS:A427MJ - TradingView — Track All Markets
Diluted earnings per share (diluted EPS) of XORTX Therapeutics, Inc. – LS:A427MJ - TradingView — Track All Markets
Long term debt to total assets ratio of XORTX Therapeutics, Inc. – LSX:A427MJ - TradingView
Non-operating income (total) of XORTX Therapeutics, Inc. – LS:A427MJ - TradingView — Track All Markets
EBIT per share of XORTX Therapeutics, Inc. – LSX:A427MJ - TradingView — Track All Markets
EBITDA margin % of XORTX Therapeutics, Inc. – LS:A427MJ - TradingView — Track All Markets
Net margin % of XORTX Therapeutics, Inc. – LS:A427MJ - TradingView — Track All Markets
Enterprise value to EBITDA ratio of XORTX Therapeutics, Inc. – LS:A427MJ - TradingView — Track All Markets
Net current asset value per share of XORTX Therapeutics, Inc. – LS:A427MJ - TradingView — Track All Markets
Operating margin % of XORTX Therapeutics, Inc. – LSX:A427MJ - TradingView — Track All Markets
Non-controlling/minority interest of XORTX Therapeutics, Inc. – LSX:A427MJ - TradingView — Track All Markets
Price to sales ratio of XORTX Therapeutics, Inc. – LS:A427MJ - TradingView
Debt to assets ratio of XORTX Therapeutics, Inc. – LSX:A427MJ - TradingView — Track All Markets
Price to cash flow ratio of XORTX Therapeutics, Inc. – LSX:A427MJ - TradingView — Track All Markets
Price to cash flow ratio of XORTX Therapeutics, Inc. – LS:A427MJ - TradingView — Track All Markets
Diluted shares outstanding of XORTX Therapeutics, Inc. – LSX:A427MJ - TradingView — Track All Markets
Tangible book value per share of XORTX Therapeutics, Inc. – LS:A427MJ - TradingView — Track All Markets
Price to book ratio of XORTX Therapeutics, Inc. – LS:A427MJ - TradingView — Track All Markets
Return on equity % of XORTX Therapeutics, Inc. – LS:A427MJ - TradingView
CapEx per share of XORTX Therapeutics, Inc. – LS:A427MJ - TradingView — Track All Markets
3.67%
자본화:
|
볼륨(24시간):